Implementing specificity of HPV-DNA primary screening in a successful organised cervical cancer prevention programme

Gynecologic Oncology

Volumn 128, Issue 3, 2013, Pages 427-432

  Zappacosta, Roberta ^a   Caraceni, Donatella ^b   Ciccocioppo, Lucia ^b   Rotondo, Tiziana ^b   Capanna, Serena ^a   Gatta, Daniela Maria Pia ^a   D'Angelo, Chiara ^a   Rosini, Sandra ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b F Renzetti Hospital   (Italy)

Author keywords

Cervical cancer screening; Dual stain; Dual test; HPV DNA test; mRNA test; p16 Ki 67

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN E6; PROTEIN E7; VIRUS DNA;

ADULT; ARTICLE; CANCER PREVENTION; CANCER SCREENING; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NONHUMAN; PILOT STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RNA, MESSENGER; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VIRAL ENVELOPE PROTEINS;

EID: 84873726677     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.11.030     Document Type: Article

References (38)

1. P. Naucler, W. Ryd, S. Tornberg, A. Strand, G. Wadell, and K. Elfgren Human papillomavirus and Papanicolaou tests to screen for cervical cancer N Engl J Med 357 2007 1589 1597
2. N.W. Belkmans, J. Berkhof, L. Rozendaal, F.J. van Kemenade, A.J. Boeke, and S. Bulk Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomized controlled implementation trial Lancet 370 2007 1764 1772
3. M.H. Mayrand, E. Duarte-Franco, and I. Rodrigues Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer NEJM 357 2007 1579 1588
4. P. Naucler, W. Ryd, and S. Tornberg Human papillomavirus and Papanicolaou tests to screen for cervical cancer NEJM 357 2007 1589 1597
5. G. Ronco, P. Giorgi-Rossi, and F. Carozzi Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test JNCI 100 2008 492 501
6. G. Ronco, P. Giorgi-Rossi, and F. Carozzi Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial Lancet Oncol 7 2006 547 555
7. M. Arbyn, P. Martin-Hirsch, F. Buntinx, M. Van Ranst, E. Paraskevaidis, and J. Dillner Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate J Cell Mol Med 13 2009 648 659
8. R. Sankaranarayanan, B.M. Nene, and S.S. Shastri HPV screening for cervical cancer in rural India NEJM 360 2009 1385 1394
9. A. Anttila, L. Kotaniemi-Talonen, M. Leinonen, M. Hakama, P. Laurila, and J.N. Tarkkanen Malila Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme BMJ 27 2010 340 350
10. M. Arbyn, C. Conco, and C.J. Meijer Trials comparing cytology with human Papillomavirus screening Lancet Oncol 10 2009 935 936
11. F. Carozzi, M. Confortini, P.P. Dalla Palma, A. Del Mistro, A. Gillio-Tos, and L. De Marco Use of p16INK4a overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomized controlled trial Lancet Oncol 9 2008 937 945
12. J. Doorbar The papillomavirus life cycle J Clin Virol 32S 2005 7 15
13. K.J. Denton, C. Bergeron, P. Klement, M.J. Trunk, T. Keller, and R. Ridder European CINtec Cytology Study Group. The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results Am J Clin Pathol 134 2010 12 21
14. M. Benevolo, A. Vocaturo, D. Caraceni, D. French, S. Rosini, and R. Zappacosta Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test J Clin Microbiol 49 2011 2643 2650
15. M. Bibbo, J. DeCecco, and A.J. Kovatich P16INK4a as an adjunct test in liquid-based cytology Anal Quant Cytol Histol 25 2003 8 11
16. N. Wentzensen, S. Vinokurova, and D.M. von Knebel Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer in the female lower genital tract Cancer Res 64 2004 3878 3884
17. T. Scholzen, and J. Gerdes The Ki-67 protein: from the known and the unknown J Cell Physiol 182 2000 311 322
18. INK4a are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia Am J Surg Pathol 25 2001 884 891
19. L. Luzzatto, C. van Haaften, and M.E. Boon Proliferation patterns of cervical cells as visualized in Leiden liquid cytology slides Diagn Cytopathol 31 2004 5 9
20. S. Sahebali, C.E. Depuydt, K. Segers, A.J. Vareecken, E. Van Marck, and J.J. Bogers Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool? J Clin Pathol 56 2003 681 686
21. N. Wentzensen, S. Vinokurova, and M. von Knebel Doeberitz Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer in the female lower genital tract Cancer Res 64 2004 3878 3884
22. M.T. Galgano, P.E. Castle, K.A. Atkins, W.T. Brix, S.R. Nassau, and M.H. Stoler Using biomarkers as objective standards in the diagnosis of cervical biopsies Am J Surg Pathol 34 2010 1077 1087
23. D. Solomon, D. Davey, R. Kurman, A. Moriarty, D. O'Connor, and M. Prey The 2001 Bethesda System: terminology for reporting results of cervical cytology JAMA 287 2002 2114 2119
24. M. Leinonen, P. Nieminen, L. Kotaniemi-Talonen, N. Malila, J. Tarkkanen, and P. Laurila Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting J Natl Cancer Inst 101 2009 1612 1623
25. International Agency for Research and Cancer Human Papillomaviruses Lyon IARC Monographs on the evaluation of carcinogenic risks to humans vol. 90 2007 IARC Monographs Press 33
26. T.C. Wright, and M. Schiffman Adding a test for human papillomavirus DNA to cervical-cancer screening NEJM 348 2003 489 490
27. K.U. Petry, D. Schmidt, S. Scherbring, A. Luyten, A. Reinecke- Lüthge, and C. Bergeron Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology Gynecol Oncol 121 2011 505 509
28. M.G. Donà, A. Vocaturo, M. Giuliani, L. Ronchetti, F. Rollo, and E. Pescarmona p16/Ki-67 dual-staining in cervico-vaginal cytology: correlation with histology, human papillomavirus detection and genotyping in women undergoing colposcopy Gynecol Oncol 126 2012 198 202
29. D. Schmidt, C. Bergeron, K.J. Denton, R. Ridder for the European CINtec Cytology Study Group p16/Ki-67 Dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology Cancer Cytopathol 119 2011 158 166
30. T. Molden, J.F. Nygard, I. Kraus, F. Karlsen, M. Nygard, and G.B. Skare Predicting CIN2 + when detecting HPV mRNA 24 and DNA by PreTect HPV-proofer and consensus PCR: a 2-year follow-up of 25 women with ASCUS or LSIL Pap smear Int J Cancer 10 2005 973 977
31. I. Kraus, T. Molden, R. Holm, A.K. Lie, F. Karlsen, and G.B. Kristensen Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas J Clin Microbiol 44 2006 1310 1317
32. A. Szarewski, L. Ambroisine, L. Cadman, J. Austin, L. Ho, and G. Terry Comparison of predictors for high-grade cervical ntraepithelial neoplasia in women with abnormal smears Cancer Epidemiol Biomarkers Prev 17 2008 3033 3042
33. A. Frega, L. Lorenzon, and M.R. Giovagnoli Prognostic implication of high risk human papillomavirus E6 and E7 mRNA in patients with intraepithelial lesions of the cervix in relationship to age Int J Immunopathol Pharmacol 24 2011 461 470
34. C. Zhao, P. Kalposi-Novak, and R.M. Austin Follow-up findings in young females with high-grade squamous intraepithelial lesion papanicolaou test results Arch Pathol Lab Med 135 2011 361 364
35. M.A. Nobbenhuis, T.J. Helmerhorst, and A.J. val der Brule Cytologycal regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear Lancet 358 2001 1782 1783
36. G. Ronco, A. Biggeri, M. Confortini, C. Naldoni, N. Segnan, and M. Sideri Health technology assessment report: HPV-DNA based primary screening for cervical cancer precursors Epidemiol Prev 36 2012 1 72
37. M. Arbyn, S.D. Sanjosé, M. Saraiya, M. Sideri, J. Palefsky, and C. Lacey EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease Int J Cancer 24 2012 [Epub ahead of print]
38. T.M. Wise-Draper, and S.I. Wells Papillomavirus E6 and E7 proteins and their cellular targets Front Biosci 1 2008 1003 1017